ARK ETF Trust - ARK Genomic Revolution ETF
US ˙ BATS ˙ US00214Q3020

SecurityARKG / ARK ETF Trust - ARK Genomic Revolution ETF
InstitutionAdvisor Group Holdings, Inc.
Latest Disclosed Ownership130,856 shares
Latest Disclosed Value $ 3,457,208
Advisor Group Holdings, Inc. reports 7.65% decrease in ownership of ARKG / ARK ETF Trust - ARK Genomic Revolution ETF

On May 15, 2026 - Advisor Group Holdings, Inc. filed a 13F-HR form disclosing ownership of 130,856 shares of ARK ETF Trust - ARK Genomic Revolution ETF (US:ARKG) valued at $3,457,216 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 141,692 shares of ARK ETF Trust - ARK Genomic Revolution ETF. This represents a change in shares of -7.65% during the quarter. The current value of the position is $4,371,899 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ARK ETF TR GENOMIC REV ETF 00214Q302 130,856 -10,836 -7.65 3,457 -15.77 0.0029
2026-02-17 2025-12-31 13F ARK ETF TR GENOMIC REV ETF 00214Q302 141,692 44,098 45.19 4,105 64.62 0.0060
2025-11-14 2025-09-30 13F ARK ETF TR GENOMIC REV ETF 00214Q302 97,594 -11,759 -10.75 2,494 -6.35 0.0035
2025-09-04 2025-06-30 13F/A-1 ARK ETF TR GENOMIC REV ETF 00214Q302 109,353 15,072 15.99 2,663 36.02 0.0047
2025-08-13 2025-06-30 13F ARK ETF TR GENOMIC REV ETF 00214Q302 89,540 -4,741 2,119 0.0025
2025-05-12 2025-03-31 13F ARK ETF TR GENOMIC REV ETF 00214Q302 94,281 1,181 1.27 1,957 -10.72 0.0044
2025-06-06 2024-12-31 13F/A-1 ARK ETF TR GENOMIC REV ETF 00214Q302 93,100 -3,001 -3.12 2,193 -10.89 0.0049
2025-02-07 2024-12-31 13F ARK ETF TR GENOMIC REV ETF 00214Q302 84,314 -11,787 2,125 0.0054
2024-11-13 2024-09-30 13F ARK ETF TR GENOMIC REV ETF 00214Q302 96,101 -8,451 -8.08 2,461 0.24 0.0055
2024-08-13 2024-06-30 13F ARK ETF TR GENOMIC REV ETF 00214Q302 104,552 -76,920 -42.39 2,455 -52.93 0.0058
2024-05-10 2024-03-31 13F ARK ETF TR GENOMIC REV ETF 00214Q302 181,472 -14,437 -7.37 5,214 -18.90 0.0116
2024-02-12 2023-12-31 13F ARK ETF TR GENOMIC REV ETF 00214Q302 195,909 -81,879 -29.48 6,428 -16.78 0.0112
2023-11-13 2023-09-30 13F ARK ETF TR GENOMIC REV ETF 00214Q302 277,788 6,350 2.34 7,725 -16.62 0.0114
2023-08-21 2023-06-30 13F/A-1 ARK ETF TR GENOMIC REV ETF 00214Q302 271,438 -11,305 -4.00 9,265 9.04 0.0166
2023-08-10 2023-06-30 13F ARK ETF TR GENOMIC REV ETF 00214Q302 271,438 -11,305 9,265 0.0025
2023-05-12 2023-03-31 13F ARK ETF TR GENOMIC REV ETF 00214Q302 282,743 13,979 5.20 8,496 11.98 0.0160
2023-02-10 2022-12-31 13F ARK ETF TR GENOMIC REV ETF 00214Q302 268,764 -17,769 -6.20 7,588 -19.46 0.0154
2022-11-14 2022-09-30 13F ARK ETF TR GENOMIC REV ETF 00214Q302 286,533 -9,736 -3.29 9,420 0.61 0.0215
2022-08-10 2022-06-30 13F ARK ETF TR GENOMIC REV ETF 00214Q302 296,269 -28,567 -8.79 9,363 -31.57 0.0206
2022-05-04 2022-03-31 13F ARK ETF TR GENOMIC REV ETF 00214Q302 324,836 -100,667 -23.66 13,683 -47.58 0.0266
2022-02-03 2021-12-31 13F ARK ETF TR GENOMIC REV ETF 00214Q302 425,503 -94,421 -18.16 26,101 -32.82 0.0494
2021-11-05 2021-09-30 13F ARK ETF TR GENOMIC REV ETF 00214Q302 519,924 -47,025 -8.29 38,854 -25.93 0.0810
2021-08-02 2021-06-30 13F ARK ETF TR GENOMIC REV ETF 00214Q302 566,949 -8,370 -1.45 52,453 2.73 0.1135
2021-05-13 2021-03-31 13F ARK ETF TR GENOMIC REV ETF 00214Q302 575,319 54,423 10.45 51,061 5.11 0.1228
2021-02-10 2020-12-31 13F ARK ETF TR GENOMIC REV ETF 00214Q302 520,896 283,296 119.23 48,579 229.66 0.1297
2020-11-12 2020-09-30 13F ARK ETF TR GENOMIC REV ETF 00214Q302 237,600 90,042 61.02 14,736 98.46 0.0441
2020-08-14 2020-06-30 13F ARK ETF TR GENOMIC REV ETF 00214Q302 147,558 36,722 33.13 7,425 123.85 0.0249
2020-05-18 2020-03-31 13F ARK ETF TR GENOMIC REV ETF 00214Q302 110,836 110,836 3,317 0.0136
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.